1.A clinical research of transurethral plasmakinetic resection of prostate for benign prostatic hyperpla-sia
Hongbing MEI ; Feng WANG ; Jiangping CHANG ; Shaoming ZENG ; Feng WU ; Ming SHI ; Shaobo YE ; Wanhua ZHEN ; Zhonglin ZHANG ; Xintao ZHANG ; Jianli CHENG
Journal of Chinese Physician 2010;(z1):3-5
Objective To investigate clinical efficacy and safety and complications of transurethral plasmakinetic resection of prostate ( PKRP) for benign prostatic hyperplasia ( BPH) .Methods Totally 186 BPH patients were underwent PKRP .Comparison of clinical parameters before and after operation .Results Following-up at 3 and 6 months after the operation showed that international prostate symptom score ( IP-SS),quality of life(QQL),residual urine volume(RUV) scores increased and maximal urinary flow rate ( Qmax) scores decreased .The incidence of complications was 8.2%.Conclusion PKRP have efficacy in the treatment of BPH , and PKRP is safer and less complications .
2.Treatment of acute renal failure induced by uretericobstruction with Ureteroscope pneumatic litho-tripsy (report of 25 cases)
Hongbing MEI ; Feng WANG ; Jiangping CHANG ; Shaoming ZENG ; Feng WU ; Ming SHI ; Shaobo YE ; Wanhua ZHEN ; Zonglin ZHANG ; Xintao ZHANG ; Jianli CHENG
Journal of Chinese Physician 2010;(z1):36-37
Objective To study the treatment of acute renal failure induced by uretericobstruction . Methods Twenty-five cases of acute renal failure induced by uretericobstruction were emergent managed with ureteroscope pneumatic lithotripsy .Results All the renal function resumed well , BUN,Cr in serum was natural or near natural .Conclusion Ureteroscope pneumatic lithotripsy should be used for acute renal failure induced by uretericobstruction as first-line.
3.The nephrogenic adenoma of the bladder: 8 cases and literature review
Yiming LAI ; Shan ZHANG ; Guohui HUANG ; Kun XIA ; Shengmeng PENG ; Wanhua WU ; Huiyang FAN ; Zhen LEI ; Zhenghui GUO
Chinese Journal of Urology 2020;41(3):190-193
Objective:To analyze the clinical characteristics of nephrogenic adenoma of the bladder.Methods:The clinical and pathological data of 8 patients with bladder nephrogenic adenoma, during the period from July 2016 to June 2019, were retrospectively analyzed. Patients’ age were 33 to 71 years old and the average age was 55, including 5 males and 3 females. The clinical manifestations were hematuria in 7 cases, urinary tract irritation in 6 cases, and no obvious symptoms in 1 case. There were 7 cases with cystitis, 3 cases with urolithiasis, 2 cases with bladder cancer, 1 case with invasive colonic mesentery fibroma, and 1 case without other complications. 5 cases had the history of urological operation. The predilection site was the lateral wall with 5cases; 5 cases were solitary; the average maximum diameter of the tumor was 0.9 cm (range 0.1-1.8 cm). Under cystoscope, papillary mass can be seen, the surface is bright red, the pedicle is not obvious, the papilla is thick and short, easy to bleed when touching; some of them are scattered and lichen like changes. All patients received transurethral resection of bladder mucosa.Results:Pathological examination shows that the bladder mucosa showed chronic inflammation, interstitial edema, granulation tissue hyperplasia, eosinophil infiltration and metaplasia of mesonephroid epithelium. All of the 8 patients were followed up by telephone for 2 to 38 months, with an average of 17.1 months. So far, neither recurrence has been detected.Conclusions:The diagnosis of nephrogenic adenoma of the bladder depends on pathological examination. It must be totally removed during operation. The recurrence and malignancy should be treated in time after operation.
4.Mechanism of action of ferroptosis in cholangiocarcinoma
Mingyu YANG ; Zhen YANG ; Wanhua REN
Journal of Clinical Hepatology 2022;38(4):951-955
The incidence and mortality rates of cholangiocarcinoma (CCA) are increasing constantly, and it is of great importance to explore new therapeutic targets. Ferroptosis, a unique pattern of cell death caused by iron-dependent cellular oxidative injury, is closely associated with iron metabolism and oxidative stress imbalance in cancer and has become a research hotspot in the field of tumor. This article introduces the mechanism of ferroptosis and the research advances in ferroptosis involved in the development and progression of CCA, and it is pointed out that the regulatory mechanism of ferroptosis has an important clinical value in the malignant progression of CCA.